# Stewart Information Services Corp: financial statements, quarterly

STC · NYSE · CIK 94344 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stc.md) · [Financials](/companies/stc/financials.md) · [Filings](/companies/stc/filings.md) · [Insiders](/companies/stc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [590](/filings/0000094344-23-000020.md) | [564 d](/filings/0000094344-24-000005.md) | [534](/filings/0000094344-24-000009.md) | [602](/filings/0000094344-25-000017.md) | [668](/filings/0000094344-25-000023.md) | [666 d](/filings/0000094344-26-000007.md) | [612](/filings/0000094344-26-000013.md) | [722](/filings/0000094344-26-000016.md) | [797](/filings/0000094344-25-000023.md) | [791 d](/filings/0000094344-26-000007.md) | [781](/filings/0000094344-26-000013.md) | [899](/filings/0000094344-26-000016.md) |
| Interest expense | $m | [5.1](/filings/0000094344-23-000020.md) | [5.0 d](/filings/0000094344-24-000005.md) | [5.1](/filings/0000094344-24-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.1](/filings/0000094344-24-000018.md) | [5.7 d](/filings/0000094344-26-000007.md) | [0.9](/filings/0000094344-25-000012.md) | [7.9](/filings/0000094344-25-000017.md) | [9.1](/filings/0000094344-25-000023.md) | [8.2 d](/filings/0000094344-26-000007.md) | [0.5](/filings/0000094344-26-000013.md) | [11.1](/filings/0000094344-26-000016.md) | [13.0](/filings/0000094344-25-000023.md) | [10.8 d](/filings/0000094344-26-000007.md) | [4.6](/filings/0000094344-26-000013.md) | [13.3](/filings/0000094344-26-000016.md) |
| Net income | $m | [14.0](/filings/0000094344-24-000018.md) | [8.8 d](/filings/0000094344-26-000007.md) | [3.1](/filings/0000094344-25-000012.md) | [17.3](/filings/0000094344-25-000017.md) | [30.1](/filings/0000094344-25-000023.md) | [22.7 d](/filings/0000094344-26-000007.md) | [3.1](/filings/0000094344-26-000013.md) | [31.9](/filings/0000094344-26-000016.md) | [44.3](/filings/0000094344-25-000023.md) | [36.3 d](/filings/0000094344-26-000007.md) | [17.0](/filings/0000094344-26-000013.md) | [37.2](/filings/0000094344-26-000016.md) |
| Diluted EPS | $ per share | [0.51](/filings/0000094344-24-000018.md) | not reported | [0.11](/filings/0000094344-25-000012.md) | [0.62](/filings/0000094344-25-000017.md) | [1.07](/filings/0000094344-25-000023.md) | not reported | [0.11](/filings/0000094344-26-000013.md) | [1.13](/filings/0000094344-26-000016.md) | [1.55](/filings/0000094344-25-000023.md) | not reported | [0.55](/filings/0000094344-26-000013.md) | [1.21](/filings/0000094344-26-000016.md) |
| Basic EPS | $ per share | [0.51](/filings/0000094344-24-000018.md) | not reported | [0.11](/filings/0000094344-25-000012.md) | [0.63](/filings/0000094344-25-000017.md) | [1.09](/filings/0000094344-25-000023.md) | not reported | [0.11](/filings/0000094344-26-000013.md) | [1.14](/filings/0000094344-26-000016.md) | [1.58](/filings/0000094344-25-000023.md) | not reported | [0.56](/filings/0000094344-26-000013.md) | [1.22](/filings/0000094344-26-000016.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [203](/filings/0000094344-23-000020.md) | [233](/filings/0000094344-25-000004.md) | [138](/filings/0000094344-24-000009.md) | [133](/filings/0000094344-24-000015.md) | [184](/filings/0000094344-24-000018.md) | [216](/filings/0000094344-26-000007.md) | [149](/filings/0000094344-25-000012.md) | [178](/filings/0000094344-25-000017.md) | [189](/filings/0000094344-25-000023.md) | [322](/filings/0000094344-26-000016.md) | [271](/filings/0000094344-26-000013.md) | [262](/filings/0000094344-26-000016.md) |
| Total assets | $m | [2,669](/filings/0000094344-23-000020.md) | [2,703](/filings/0000094344-25-000004.md) | [2,651](/filings/0000094344-24-000009.md) | [2,645](/filings/0000094344-24-000015.md) | [2,730](/filings/0000094344-24-000018.md) | [2,730](/filings/0000094344-26-000007.md) | [2,707](/filings/0000094344-25-000012.md) | [2,781](/filings/0000094344-25-000017.md) | [2,846](/filings/0000094344-25-000023.md) | [3,253](/filings/0000094344-26-000016.md) | [3,238](/filings/0000094344-26-000013.md) | [3,292](/filings/0000094344-26-000016.md) |
| Total liabilities | $m | [1,310](/filings/0000094344-23-000020.md) | [1,324](/filings/0000094344-25-000004.md) | [1,287](/filings/0000094344-24-000009.md) | [1,274](/filings/0000094344-24-000015.md) | [1,315](/filings/0000094344-24-000018.md) | [1,319](/filings/0000094344-26-000007.md) | [1,299](/filings/0000094344-25-000012.md) | [1,335](/filings/0000094344-25-000017.md) | [1,364](/filings/0000094344-25-000023.md) | [1,602](/filings/0000094344-26-000016.md) | [1,592](/filings/0000094344-26-000013.md) | [1,619](/filings/0000094344-26-000016.md) |
| Long-term debt | $m | not reported | [445](/filings/0000094344-25-000004.md) | not reported | not reported | not reported | [446](/filings/0000094344-25-000004.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,352](/filings/0000094344-23-000020.md) | [1,371](/filings/0000094344-25-000004.md) | [1,358](/filings/0000094344-24-000009.md) | [1,365](/filings/0000094344-24-000015.md) | [1,407](/filings/0000094344-24-000018.md) | [1,402](/filings/0000094344-26-000007.md) | [1,400](/filings/0000094344-25-000012.md) | [1,438](/filings/0000094344-25-000017.md) | [1,473](/filings/0000094344-25-000023.md) | [1,641](/filings/0000094344-26-000016.md) | [1,638](/filings/0000094344-26-000013.md) | [1,663](/filings/0000094344-26-000016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [59.5 d](/filings/0000094344-24-000018.md) | [39.5 d](/filings/0000094344-26-000007.md) | [(29.6)](/filings/0000094344-25-000012.md) | [21.1 d](/filings/0000094344-25-000017.md) | [76.1 d](/filings/0000094344-25-000023.md) | [68.0 d](/filings/0000094344-26-000007.md) | [(29.9)](/filings/0000094344-26-000013.md) | [53.4 d](/filings/0000094344-26-000016.md) | [92.6 d](/filings/0000094344-25-000023.md) | [89.5 d](/filings/0000094344-26-000007.md) | [(4.5)](/filings/0000094344-26-000013.md) | [60.5 d](/filings/0000094344-26-000016.md) |
| Capital expenditure | $m | [14.0 d](/filings/0000094344-24-000018.md) | [8.3 d](/filings/0000094344-26-000007.md) | [10.2](/filings/0000094344-25-000012.md) | [9.2 d](/filings/0000094344-25-000017.md) | [8.7 d](/filings/0000094344-25-000023.md) | [12.3 d](/filings/0000094344-26-000007.md) | [12.3](/filings/0000094344-26-000013.md) | [14.8 d](/filings/0000094344-26-000016.md) | [19.1 d](/filings/0000094344-25-000023.md) | [27.2 d](/filings/0000094344-26-000007.md) | [16.4](/filings/0000094344-26-000013.md) | [25.5 d](/filings/0000094344-26-000016.md) |
| Dividends paid | $m | [13.0 d](/filings/0000094344-24-000018.md) | [13.0 d](/filings/0000094344-26-000007.md) | [13.1](/filings/0000094344-25-000012.md) | [13.1 d](/filings/0000094344-25-000017.md) | [13.9 d](/filings/0000094344-25-000023.md) | [13.9 d](/filings/0000094344-26-000007.md) | [13.9](/filings/0000094344-26-000013.md) | [14.0 d](/filings/0000094344-26-000016.md) | [14.7 d](/filings/0000094344-25-000023.md) | [15.9 d](/filings/0000094344-26-000007.md) | [16.3](/filings/0000094344-26-000013.md) | [16.4 d](/filings/0000094344-26-000016.md) |
| Share repurchases | $m | [0.2 d](/filings/0000094344-24-000018.md) | [0.2 d](/filings/0000094344-26-000007.md) | [3.4](/filings/0000094344-25-000012.md) | [0.1 d](/filings/0000094344-25-000017.md) | [0.1 d](/filings/0000094344-25-000023.md) | [0.2 d](/filings/0000094344-26-000007.md) | [3.4](/filings/0000094344-26-000013.md) | [0.1 d](/filings/0000094344-26-000016.md) | [0.1 d](/filings/0000094344-25-000023.md) | [0.3 d](/filings/0000094344-26-000007.md) | [5.2](/filings/0000094344-26-000013.md) | [0.1 d](/filings/0000094344-26-000016.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.4](/filings/0000094344-23-000020.md) | [27.2](/filings/0000094344-24-000009.md) | [27.4](/filings/0000094344-24-000015.md) | [27.7](/filings/0000094344-24-000018.md) | [28.0](/filings/0000094344-25-000012.md) | [28.0](/filings/0000094344-25-000017.md) | [28.2](/filings/0000094344-25-000023.md) | [28.3](/filings/0000094344-26-000013.md) | [28.3](/filings/0000094344-26-000016.md) | [28.5](/filings/0000094344-25-000023.md) | [30.8](/filings/0000094344-26-000013.md) | [30.9](/filings/0000094344-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,522,199 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0000094344-26-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.